AMERICAN CENTURY COMPANIES INC

Position in JANX — Janux Therapeutics, Inc.

CIK 748054 KANSAS CITY, MO

Position in JANX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$713,871

+$293,883 QoQ

Shares Held

46,476

+53.8% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#82

of 198 holders

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AMERICAN CENTURY COMPANIES INC holds $3,618,743,392 across 179 Biotechnology names. JANX ranks #104 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,853,956	$558,096,374
2	ASND	Ascendis Pharma A/S	1,400,575	$373,561,364
3	VRTX	Vertex Pharmaceuticals Inc / Ma	580,901	$288,550,953
4	ARGX	Argenx SE	173,193	$160,683,269
5	IONS	Ionis Pharmaceuticals Inc	1,947,076	$154,383,656
6	EXEL	Exelixis, Inc.	1,791,664	$97,484,438
7	HRMY	Harmony Biosciences Holdings, Inc.	2,539,512	$92,463,631
8	GPCR	Structure Therapeutics Inc.	1,682,179	$90,282,546

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$713,871	46,476	+53.8%	Shares	Defined	2026-08-12
2026-03-31	$419,988	30,215	+9.1%	Shares	Defined	2026-05-15
2025-12-31	$382,135	27,691	+46.1%	Shares	Defined	2026-02-13
2025-09-30	$463,211	18,953	+67.9%	Shares	Defined	2025-11-12
2025-06-30	$260,799	11,290	+100.6%	Shares	Defined	2025-08-12
2024-06-30	$235,715	5,627	-79.2%	Shares	Defined	2024-08-07
2024-03-31	$1,018,620	27,055	+136.4%	Shares	Defined	2024-05-14
2023-12-31	$122,783	11,443	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.